Furthermore, a recent investigation revealed an enrichment of short-chain fatty acid (SCFA)-producing bacteria in patients with MASLD-HCC, leading to an immunomodulatory shift towards immunosuppression marked by elevated IL-10+ Tregs and reduced CD8+ T cells (61). Here, IL10 is linked to hepatocellular carcinoma.